top of page

Diabetes, Mood Disorders and ADHD; Brain Hazards and Implications for Improving Clinical Outcomes

Date: May 12, 2018

Location: Missassauga, Ontario, Canada

​

This archived, self-directed learning activity is available for personal viewing and is based on the live event held in Missasauga, Ontario on May 12 2018.  The program involved a multidisciplinary faculty of clinician researchers from Johns Hopkins University School of Medicine, Mount Sinai Hospital, and the University of Toronto. The overarching aim of this learning activity was to:

​

1. To discuss the hazards on brain function imposed by diabetes mellitus

​

2. To discuss convergent psychopathology in patients with diabetes, mood disorders and ADHD.

​

3. To provide practical up to date info on treatment of diabetes mellitus, mood disorders, ADHD with an aim to reduce brain hazards and improve health outcomes

The Panel

Roger McIntyre, MD, FRCPC
Professor of Psychiatry and Pharmacology 
Executive Director, BCDF
Head, Mood Disorders Psychopharmacology Unit 
University of Toronto 

David W. Goodman, MD

Assistant Professor of Psychiatry and Behavioral Sciences at the Johns Hopkins University School of Medicine

Director of the Adult Attention Deficit Disorder Center of Maryland in Lutherville

Director of Suburban Psychiatric Associates, LLC

Harpreet Singh Bajaj, MD, MPH, ECNU, FACE

Endocrinologist and Epidemiologist, LMC Diabetes & Endocrinology, Brampton, ON

Research Associate, Leadership Sinai Centre for Diabetes, Mount Sinai Hospital, Toronto

Co-Chair, Marketing & Communication, Diabetes Canada National Professional Section

Columnist and blogger, www.medscape.com

Founder, “STOP Diabetes” Foundation Inc.

bottom of page